Literature DB >> 9373598

Regression of cardiac involvement by malignant melanoma following lomustine chemotherapy.

M R Carpenter1, M Vassallo, I M Peat, A J Scriven.   

Abstract

Cardiac involvement by malignant melanoma is usually a premorbid event. We present a case of presumed cardiac involvement by malignant melanoma with regression following chemotherapy as demonstrated by transoesophageal echocardiography.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9373598      PMCID： PMC2431443          DOI： 10.1136/pgmj.73.863.571

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  5 in total

1.  Intracardiac metastases, report of three cases.

Authors:  V Lustig; L T Vlasveld; R H Bakker; J E Schreuder; W J Mooi; W W ten Bokkel Huinink
Journal:  Neth J Med       Date:  1991-02       Impact factor: 1.422

2.  The heart in malignant melanoma. A study of 70 autopsy cases.

Authors:  D L Glancy; W C Roberts
Journal:  Am J Cardiol       Date:  1968-04       Impact factor: 2.778

3.  Metastatic malignant melanoma initially seen as congestive heart failure: diagnosis by transesophageal echocardiography.

Authors:  B Schneider; T Zienkiewicz; B Langenstein; M Vierbuchen; T Meinertz
Journal:  Am Heart J       Date:  1994-08       Impact factor: 4.749

4.  Metastatic tumors of the heart detected by two-dimensional echocardiography.

Authors:  S P Kutalek; I P Panidis; M N Kotler; G S Mintz; J Carver; J J Ross
Journal:  Am Heart J       Date:  1985-02       Impact factor: 4.749

5.  Metastatic and invasive tumours involving the heart in a geriatric population: a necropsy study.

Authors:  W MacGee
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.